The strategic slowdown in the diagnostics sector continues. Late February to March was relatively light in both deal volume and value, especially compared to the same period in 2017. As usual, the … [Read more...]
PARTNERSHIPS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
April 4, 2018
MARKETING
Theranos & Its CEO Settle Stock Fraud Charges with SEC
April 4, 2018
Seven years ago, Theranos was a $9 billion dynamo seemingly on the precipice of blowing the blood testing market wide open. Today, the company and its CEO and founder, Elizabeth Holmes, are a … [Read more...]
DISTRIBUTION AGREEMENTS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
April 3, 2018
Based on the early returns, the market analysts that predicted 2018 would see a slowdown in strategic Dx deal making appear to be right. But while deal volume was low on both the M&A and alliance … [Read more...]
MARKETING
Theranos & Its CEO Settle Stock Fraud Charges with SEC
March 20, 2018
CMS; The Arizona Attorney General; Walgreen's; Its own shareholders. And now Theranos has a new legal adversary: the US Securities Exchange Commission which has charged Theranos and its founder … [Read more...]
INTELLECTUAL PROPERTY
Happy Endings: Guardant & Foundation Make Sweet Lemonade Out of False Advertising Lemons
March 20, 2018
In June 2017, Guardant Health sued Foundation Medicine for making false statements about the Guardant360 test in its advertisements for the FoundationACT liquid biopsy genomic profiling test. … [Read more...]
PARTNERSHIPS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
March 12, 2018
As the calendar turned to 2018 and Medicare turned to PAMA, diagnostic deal making revved up. Deal volume was relatively heavy although short on drama. But what looks to be a big year is just … [Read more...]
MERGERS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
January 2, 2018
Good news for any of you who slept through December 2017: You didn't miss much—at least as far as blockbuster strategic deals in the clinical laboratory space are concerned. M&AIn contrast to … [Read more...]
DISTRIBUTION AGREEMENTS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
December 5, 2017
The pattern of high volume and relatively low impact continued with strategic alliances outnumbering acquisitions at rate of roughly 3:1. M&A Following the trio of mega-deal closings, … [Read more...]
MARKETING
Report: Outreach Labs Remain Profitable Despite Antiquated Systems & Lack of Exec Respect
November 16, 2017
Hidden within the basement of your average hospital is a $24 million business, one that provides a top quality, must-have service and operates at a margin of around 25% to 30%. That business is the … [Read more...]
GREAT TRANSITION UNDERWAY
Laboratories Increasing Customer-Focus
October 30, 2017
Laboratories have always had a strong service component—both for their referring physicians and the patient. However, laboratories are now in the midst of a great transition, where a concerted … [Read more...]
